628 results
Page 2 of 32
8-K
EX-99.1
6beo ptic
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
zjlkl jrl00wvjk
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
orf9upx10kfbgg4ujc
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
kw9yr7ewjl8zp i5
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
rftzqz4kedf3
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
x8x14n
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
hrc5d832d9oxi1v7i5f
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
yzjl5
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
iaph850j
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
thoe0zihu b4rxr
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
qek87pe
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
74urc09
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
efemmk
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
EX-99.1
xu9kgvr2ekm8 ebgkk
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
qicijzlpbzufu3k uu
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
igsmuu8
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.1
797uuq
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
6zevo0 siarlrzi
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
9gxkcx
10 Oct 23
Additional proxy materials by non-management
6:48am